Adam Orsborn

Papers

1

Total Citations

25

H-Index

1

About

Adam Orsborn is a leading voice in the advancement of pharmacy automation, with a focused expertise in the safe and efficient compounding of intravenous (IV) medications. His most influential work centers on the integration of robotic technology into clinical practice, specifically through the use of the APOTECAchemo system. Orsborn’s major contribution is the development of international, consensus-based recommendations for implementing robotic IV compounding, a critical step in reducing human error and occupational exposure to hazardous drugs. His landmark 2016 paper, which has garnered 25 citations, serves as a foundational guide for institutions transitioning from manual to automated processes. By synthesizing the experiences of a global community of users, Orsborn has provided a practical roadmap that addresses workflow changes, safety protocols, and quality assurance. His work is not merely technical; it is a strategic framework for modernizing pharmacy practice. For students and researchers, Orsborn’s research represents a pivotal shift toward precision and safety in medication preparation, making him a key figure in the future of sterile compounding.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Robotic i.v. medication compounding: Recommendations from the international community of APOTECAchemo users
25 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 14

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago